Acuitas Lighthouse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acuitas lighthouse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acuitas Lighthouse Today - Breaking & Trending Today

Analyzing Atlas Energy Solutions (NYSE:AESI) and U.S. Silica (NYSE:SLCA)

Akumin (NASDAQ:AKU – Get Rating) and OpGen (NASDAQ:OPGN – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership. Volatility and Risk Akumin has a beta of -0.49, suggesting that […] ....

Gene Panel , Akumin Inc , Technology Platform , Opgen Inc , Get Rating , Given Opgen , Acuitas Lighthouse , Akumin Daily , Nasdaq Aku , Stock Comparison , Stock Analysis ,

Recap: OpGen Q1 Earnings


Company s 52-week low was at $1.63
Price action over last quarter: down 17.09%
Company Profile
OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company s product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base. ....

Company Profile , Opgen Inc , Amgen Inc , Acuitas Lighthouse , நிறுவனம் ப்ரொஃபைல் , கேன் இன்க் ,

OpGen Extends and Expands Partnership with New York State Department of Health to Detect Antimicrobial-Resistant Infections


Published: Apr 19, 2021
Collaboration with NYS Department of Health’s Wadsworth Center continues for extended six-month term until September 30, 2021
Project utilizes OpGen’s Acuitas® AMR Gene Panel and Acuitas Lighthouse® Software within digital health and precision medicine platform at multiple healthcare institutions
GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) OpGen, Inc.
 (Nasdaq: OPGN) announced today that its strategic collaboration with the New York State Department of Health (“DOH”) to develop a state-of-the-art solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions statewide is being extended beyond the second-year expansion phase by another six months through September 30, 2021.
Having successfully achieved all of the milestones of the first and second year phases for the development of an infectious disease digital health and precision medicine platform that connects health ....

New York , United States , Matthew Bretzius , Megan Paul , Oliver Schacht , Curetis Gmb , Opgen Acuitas , Department Of Health New York , Technology Platform , Health Wadsworth Center , Edison Group , Wadsworth Center Laboratories , Wadsworth Center Deputy , York State Department Of Health , Gene Panel , Wadsworth Center , Centers For Disease , Opgen Press Contact , York State Department , Research Use Only , Opgen Inc , Exchange Commission , Opgen Acuitas Lighthouse Software , Acuitas Lighthouse Software , Securities Exchange , Acuitas Lighthouse ,